(Q53855445)

English

Temporal trends of invasive disease due to Streptococcus pneumoniae among children in the intermountain west: emergence of nonvaccine serogroups.

scientific article

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

21 May 2018

http://europepmc.org/abstract/MED/15937758

Temporal trends of invasive disease due to Streptococcus pneumoniae among children in the intermountain west: emergence of nonvaccine serogroups. (English)

1 reference

Europe PubMed Central

PubMed publication ID

21 May 2018

http://europepmc.org/abstract/MED/15937758

Streptococcus pneumoniae

1 reference

based on heuristic

inferred from title

invasive disease

1 reference

based on heuristic

inferred from title

Carrie L. Byington

1

1 reference

Europe PubMed Central

PubMed publication ID

21 May 2018

http://europepmc.org/abstract/MED/15937758

author name string

Matthew H Samore

2

1 reference

Europe PubMed Central

PubMed publication ID

21 May 2018

http://europepmc.org/abstract/MED/15937758

Gregory J Stoddard

3

1 reference

Europe PubMed Central

PubMed publication ID

21 May 2018

http://europepmc.org/abstract/MED/15937758

Steve Barlow

4

1 reference

Europe PubMed Central

PubMed publication ID

21 May 2018

http://europepmc.org/abstract/MED/15937758

Judy Daly

5

1 reference

Europe PubMed Central

PubMed publication ID

21 May 2018

http://europepmc.org/abstract/MED/15937758

Kent Korgenski

6

1 reference

Europe PubMed Central

PubMed publication ID

21 May 2018

http://europepmc.org/abstract/MED/15937758

Sean Firth

7

1 reference

Europe PubMed Central

PubMed publication ID

21 May 2018

http://europepmc.org/abstract/MED/15937758

David Glover

8

1 reference

Europe PubMed Central

PubMed publication ID

21 May 2018

http://europepmc.org/abstract/MED/15937758

Jasmin Jensen

9

1 reference

Europe PubMed Central

PubMed publication ID

21 May 2018

http://europepmc.org/abstract/MED/15937758

Edward O Mason

10

1 reference

Europe PubMed Central

PubMed publication ID

21 May 2018

http://europepmc.org/abstract/MED/15937758

Cheryl K Shutt

11

1 reference

Europe PubMed Central

PubMed publication ID

21 May 2018

http://europepmc.org/abstract/MED/15937758

Andrew T Pavia

12

1 reference

Europe PubMed Central

PubMed publication ID

21 May 2018

http://europepmc.org/abstract/MED/15937758

language of work or name

0 references

publication date

26 May 2005

1 reference

Europe PubMed Central

PubMed publication ID

21 May 2018

http://europepmc.org/abstract/MED/15937758

Clinical Infectious Diseases

1 reference

Europe PubMed Central

PubMed publication ID

21 May 2018

http://europepmc.org/abstract/MED/15937758

41

1 reference

Europe PubMed Central

PubMed publication ID

21 May 2018

http://europepmc.org/abstract/MED/15937758

1

1 reference

Europe PubMed Central

PubMed publication ID

21 May 2018

http://europepmc.org/abstract/MED/15937758

21-29

1 reference

Europe PubMed Central

PubMed publication ID

21 May 2018

http://europepmc.org/abstract/MED/15937758

Policy Statement: Recommendations for the Prevention of Pneumococcal Infections, Including the Use of Pneumococcal Conjugate Vaccine (Prevnar), Pneumococcal Polysaccharide Vaccine, and Antibiotic Prophylaxis

1 reference

https://api.crossref.org/works/10.1086%2F430604

21 January 2018

American Academy of Pediatrics. Committee on Infectious Diseases. Technical report: prevention of pneumococcal infections, including the use of pneumococcal conjugate and polysaccharide vaccines and antibiotic prophylaxis

1 reference

https://api.crossref.org/works/10.1086%2F430604

21 January 2018

Decline in Invasive Pneumococcal Disease after the Introduction of Protein–Polysaccharide Conjugate Vaccine

1 reference

https://api.crossref.org/works/10.1086%2F430604

21 January 2018

Serotype prevalence of occult pneumococcal bacteremia

1 reference

https://api.crossref.org/works/10.1086%2F430604

21 January 2018

Historical changes in pneumococcal serogroup distribution: implications for the era of pneumococcal conjugate vaccines.

1 reference

https://api.crossref.org/works/10.1086%2F430604

21 January 2018

Which pneumococcal serogroups cause the most invasive disease: implications for conjugate vaccine formulation and use, part I.

1 reference

https://api.crossref.org/works/10.1086%2F430604

21 January 2018

Serotype distribution and antimicrobial resistance patterns of invasive isolates of Streptococcus pneumoniae: Alaska, 1991-1998.

1 reference

https://api.crossref.org/works/10.1086%2F430604

21 January 2018

Potential impact of conjugate pneumococcal vaccines on pediatric pneumococcal diseases

1 reference

https://api.crossref.org/works/10.1086%2F430604

21 January 2018

Serotypes/groups distribution and antimicrobial resistance of invasive pneumococcal isolates: implications for vaccine strategies.

1 reference

https://api.crossref.org/works/10.1086%2F430604

21 January 2018

Proportion of invasive pneumococcal infections in German children preventable by pneumococcal conjugate vaccines.

1 reference

https://api.crossref.org/works/10.1086%2F430604

21 January 2018

Geographical differences in invasive pneumococcal disease rates and serotype frequency in young children

1 reference

https://api.crossref.org/works/10.1086%2F430604

21 January 2018

A decade (1989-1998) of pediatric invasive pneumococcal disease in 2 populations residing in 1 geographic location: implications for vaccine choice

1 reference

https://api.crossref.org/works/10.1086%2F430604

21 January 2018

An epidemiological investigation of a sustained high rate of pediatric parapneumonic empyema: risk factors and microbiological associations

1 reference

https://api.crossref.org/works/10.1086%2F430604

21 January 2018

Comparison of the Denka Seiken slide agglutination method to the quellung test for serogrouping of Streptococcus pneumoniae isolates

1 reference

https://api.crossref.org/works/10.1086%2F430604

21 January 2018

Geographic distribution and clonal diversity of Streptococcus pneumoniae serotype 1 isolates.

1 reference

https://api.crossref.org/works/10.1086%2F430604

21 January 2018

Principles of multilevel modelling

1 reference

https://api.crossref.org/works/10.1086%2F430604

21 January 2018

Some comments on frequently used multiple endpoint adjustment methods in clinical trials

1 reference

https://api.crossref.org/works/10.1086%2F430604

21 January 2018

National Department of Defense Surveillance for Invasive Streptococcus pneumoniae: antibiotic resistance, serotype distribution, and arbitrarily primed polymerase chain reaction analyses

1 reference

https://api.crossref.org/works/10.1086%2F430604

21 January 2018

Association between antimicrobial resistance among pneumococcal isolates and burden of invasive pneumococcal disease in the community.

1 reference

https://api.crossref.org/works/10.1086%2F430604

21 January 2018

Constancy of distribution of serogroups of invasive pneumococcal isolates among children: experience during 4 decades.

1 reference

https://api.crossref.org/works/10.1086%2F430604

21 January 2018

Decrease of invasive pneumococcal infections in children among 8 children's hospitals in the United States after the introduction of the 7-valent pneumococcal conjugate vaccine.

1 reference

https://api.crossref.org/works/10.1086%2F430604

21 January 2018

Antibiotic resistant infections due to Streptococcus pneumoniae: impact on therapeutic options and clinical outcome

1 reference

https://api.crossref.org/works/10.1086%2F430604

21 January 2018

Clinical relevance of antimicrobial resistance in the management of pneumococcal community-acquired pneumonia

1 reference

https://api.crossref.org/works/10.1086%2F430604

21 January 2018

Clinical outcomes of pneumococcal pneumonia caused by antibiotic-resistant strains in asian countries: a study by the Asian Network for Surveillance of Resistant Pathogens.

1 reference

https://api.crossref.org/works/10.1086%2F430604

21 January 2018

Culture-negative childhood empyema is usually due to penicillin-sensitive Streptococcus pneumoniae capsular serotype 1.

1 reference

https://api.crossref.org/works/10.1086%2F430604

21 January 2018

Clinical characteristics of children with complicated pneumonia caused by Streptococcus pneumoniae

1 reference

https://api.crossref.org/works/10.1086%2F430604

21 January 2018

Clonality of Streptococcus pneumoniae serotype 1 isolates from pediatric patients in the United States

1 reference

https://api.crossref.org/works/10.1086%2F430604

21 January 2018

Severe pneumococcal pneumonia in previously healthy children: the role of preceding influenza infection

1 reference

https://api.crossref.org/works/10.1086%2F430604

21 January 2018

Clinical features, aetiology and outcome of empyema in children in the north east of England

1 reference

https://api.crossref.org/works/10.1086%2F430604

21 January 2018

Poor potential coverage for 7-valent pneumococcal conjugate vaccine, Malawi

1 reference

https://api.crossref.org/works/10.1086%2F430604

21 January 2018

Evolution of Streptococcus pneumoniae serotypes and penicillin susceptibility in Latin America, Sireva-Vigía Group, 1993 to 1999. PAHO Sireva-Vigía Study Group. Pan American Health Organization.

1 reference

https://api.crossref.org/works/10.1086%2F430604

21 January 2018

The epidemiology of invasive pneumococcal disease in children in Far North Queensland

1 reference

https://api.crossref.org/works/10.1086%2F430604

21 January 2018

Tolerability and immunogenicity of an eleven valent mixed carrier Streptococcus pneumoniae capsular polysaccharide-diphtheria toxoid or tetanus protein conjugate vaccine in Finnish and Israeli infants

1 reference

https://api.crossref.org/works/10.1086%2F430604

21 January 2018

Safety and immunogenicity of three doses of an eleven-valent diphtheria toxoid and tetanus protein--conjugated pneumococcal vaccine in Filipino infants

1 reference

https://api.crossref.org/works/10.1086%2F430604

21 January 2018

Drug‐Resistant Pneumococcal Pneumonia: Clinical Relevance and Related Factors

1 reference

https://api.crossref.org/works/10.1086%2F430604

21 January 2018

Effect of Clonal and Serotype‐Specific Properties on the Invasive Capacity ofStreptococcus pneumoniae

1 reference

https://api.crossref.org/works/10.1086%2F430604

21 January 2018

Invasive pneumococcal disease in a pediatric population, Auckland, New Zealand

1 reference

https://api.crossref.org/works/10.1086%2F430604

21 January 2018

Identifiers

1 reference

Europe PubMed Central

PubMed publication ID

21 May 2018

http://europepmc.org/abstract/MED/15937758

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

21 May 2018

http://europepmc.org/abstract/MED/15937758

ResearchGate publication ID

0 references

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q53855445&oldid=1629961032"